Chemoinformaics analysis of Beta-Acetyladonitoxin
| Molecular Weight | 822.986 | nRot | 8 |
| Heavy Atom Molecular Weight | 756.458 | nRig | 44 |
| Exact Molecular Weight | 822.44 | nRing | 8 |
| Solubility: LogS | -4.249 | nHRing | 4 |
| Solubility: LogP | 2.554 | No. of Aliphatic Rings | 8 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 124 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 58 | No. of Aromatic Carbocycles | 0 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 66 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 43 | No. of Saturated Rings | 7 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 0 |
| nHA | 15 | APOL | 127.848 |
| nHD | 5 | BPOL | 81.8357 |
| QED | 0.163 |
| Synth | 6.284 |
| Natural Product Likeliness | 1.873 |
| NR-PPAR-gamma | 0.611 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.062 |
| Pgp-sub | 0.054 |
| HIA | 0.127 |
| CACO-2 | -5.611 |
| MDCK | 0.000132585 |
| BBB | 0.082 |
| PPB | 0.590785 |
| VDSS | 0.387 |
| FU | 0.150647 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.2 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.263 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.06 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.166 |
| CYP3a4-inh | 0.055 |
| CYP3a4-sub | 0.803 |
| CL | 15.801 |
| T12 | 0.024 |
| hERG | 0.466 |
| Ames | 0.069 |
| ROA | 0.997 |
| SkinSen | 0.048 |
| Carcinogencity | 0.104 |
| EI | 0.004 |
| Respiratory | 0.856 |
| NR-Aromatase | 0.805 |
| Antiviral | Yes |
| Prediction | 0.855766 |